- Home
- TTC vs GKOS Comparison
TTC vs GKOS Comparison
Compare TTC & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTC
- GKOS
- Stock Information
- Founded
- TTC 1914
- GKOS 1998
- Country
- TTC United States
- GKOS United States
- Employees
- TTC N/A
- GKOS N/A
- Industry
- TTC Tools/Hardware
- GKOS Medical/Dental Instruments
- Sector
- TTC Consumer Discretionary
- GKOS Health Care
- Exchange
- TTC Nasdaq
- GKOS Nasdaq
- Market Cap
- TTC N/A
- GKOS 8.4B
- IPO Year
- TTC N/A
- GKOS 2015
- Fundamental
- Price
- TTC $73.27
- GKOS $102.04
- Analyst Decision
- TTC Buy
- GKOS Strong Buy
- Analyst Count
- TTC 4
- GKOS 13
- Target Price
- TTC $89.75
- GKOS $161.54
- AVG Volume (30 Days)
- TTC 1.3M
- GKOS 1.0M
- Earning Date
- TTC 03-06-2025
- GKOS 04-30-2025
- Dividend Yield
- TTC 2.07%
- GKOS N/A
- EPS Growth
- TTC 43.20
- GKOS N/A
- EPS
- TTC 3.92
- GKOS N/A
- Revenue
- TTC $4,576,900,000.00
- GKOS $383,481,000.00
- Revenue This Year
- TTC $1.60
- GKOS $27.84
- Revenue Next Year
- TTC $3.18
- GKOS $27.99
- P/E Ratio
- TTC $18.68
- GKOS N/A
- Revenue Growth
- TTC 3.87
- GKOS 21.85
- 52 Week Low
- TTC $71.23
- GKOS $88.16
- 52 Week High
- TTC $100.93
- GKOS $163.71
- Technical
- Relative Strength Index (RSI)
- TTC 41.11
- GKOS 37.88
- Support Level
- TTC $71.23
- GKOS $98.03
- Resistance Level
- TTC $75.72
- GKOS $108.62
- Average True Range (ATR)
- TTC 1.66
- GKOS 3.96
- MACD
- TTC 0.32
- GKOS 1.87
- Stochastic Oscillator
- TTC 33.12
- GKOS 47.86
About GKOS Glaukos Corporation
Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.